2021 | The 2020 revision of the guidelines for the management of myeloproliferative neoplasms | 문영철 | Review |
2016 | The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea | 문영철 | Article |
2007 | The clinical outcomes of autologous stem cell transplantation in peripheral T cell lymphoma: From retrospective Multicenter study in Korea. | 문영철 | Meeting Abstract |
2018 | The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma | 문영철 | Article |
2020 | The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study) | 문영철 | Article |
2007 | The equal activity of azacytidine in 4 risk groups of IPSS in MDS | 문영철 | Meeting Abstract |
2006 | The intention to treat analysis of the different post remission therapy modalities in AML patients with the "Intermediate Risk Group (IPG)" based on cytogenetics. | 성주명; 문영철 | Meeting Abstract |
2007 | The intention to treat analysis of the different post-remission therapy modalities in AML patients with the Intermediate Risk Group based on cytogenetics | 문영철 | Meeting Abstract |
2009 | The Level of Peroxiredoxin and Catalase On Single Cell Level Is Correlated with the Positivity of Ph Chromosome in the Bone Marrow of CML Patients During Imatinib Therapy. | 성주명; 이서구; 유은선; 허정원; 이경은; 문영철; 남은미; 우현애 | Meeting Abstract |
2006 | The LTB4 receptor is involved not only in the downstream pathway of rhG-CSF mobilization but in the LTB4 mobitization pathway in C57BL/6 mice. | 이순남; 성주명; 유은선; 이경은; 문영철 | Meeting Abstract |
2015 | The prognostic impact of inflammatory factors in patients with multiple myeloma treated with thalidomide in Korea | 문영철 | Article |
2014 | The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: A multicenter, prospective, open-label, observational study in Korea | 문영철 | Article |
2017 | The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: A retrospective multicenter study (KMM160) | 문영철 | Article |
2014 | Topoisomerase II alpha and microtubule-associated protein-tau as a predictive marker in axillary lymph node positive breast cancer | 이순남; 성순희; 성주명; 이경은; 문영철; 남은미 | Article |
2003 | Transepithelial migration of neutrophils in response to leukotriene B4 is mediated by a reactive oxygen species-extracellular signal-regulated kinase-linked cascade | 성주명; 문영철 | Article |
2014 | Transplant physicians' perceptions of cord blood transplantation in Korea: A questionnaire survey | 문영철 | Article |
2015 | Treatment outcomes of rituximab plus hyper-CVAD in korean patients with sporadic burkitt or burkitt-like lymphoma: Results of a multicenter analysis | 문영철 | Article |
2023 | Ultrasound-guided percutaneous core needle biopsy of abdominal subcutaneous fat for diagnosing amyloidosis: comparison with bone marrow biopsy | 이정경; 문영철; 김진실; 이효정 | Article |
2017 | VARIABLE NATURAL KILLER CELL ACTIVITY IN HEMATOLOGIC MALIGNANCIES AT DIAGNOSIS | 성주명; 허정원; 문영철 | Meeting Abstract |
2010 | Variant Philadelphia chromosome identified by interphase fluorescence in situ hybridization (FISH) without evidence on G-banded karyotyping and metaphase FISH | 정화순; 성주명; 허정원; 문영철 | Article |
2015 | Varicella-zoster virus-specific cell-mediated immunity and herpes zoster development in multiple myeloma patients receiving bortezomib- or thalidomide-based chemotherapy | 문영철 | Article |
2011 | Various patterns of IgH deletion identified by FISH using combined IgH and IgH/CCND1 probes in multiple myeloma and chronic lymphocytic leukemia | 정화순; 성주명; 허정원; 문영철 | Article |
2010 | VEGFA and VEGFR2 Genetic Polymorphisms and Survival In Patients with Diffuse Large B Cell Lymphoma | 정화순; 문영철 | Meeting Abstract |
2012 | VEGFA and VEGFR2 genetic polymorphisms and survival in patients with diffuse large b cell lymphoma | 정화순; 문영철 | Article |
2017 | VERY EARLY MOLECULAR RESPONSE (VEMR) WITH FRONTLINE DASATINIB TREATMENT IS A STRONG PREDICTOR OF LONG-TERM BCR-ABL1 TRANSCRIPT LEVELS IN CHRONIC MYELOID LEUKEMIA PATIENTS: PCR-DEPTH STUDY | 문영철 | Meeting Abstract |
2015 | Weekly rituximab consolidation following four cycles of R-CHOP induction chemotherapy in very elderly patients with diffuse large B-cell lymphoma: Consortium for improving survival of lymphoma study (CISL) | 문영철 | Article |